456MO METEOR-1: A phase I study of the safety and efficacy of the protein arginine methyltransferase 5 (PRMT5) inhibitor GSK3326595 in advanced solid tumors
| Autor: | Postel-Vinay, S., Italiano, A., Martin Romano, P., Cassier, P.A., Siu, L.L., Lossos, I.S., Hilton, J.F., Mckean, M.A., Strauss, J., Falchook, G.S., de Jonge, M.J.A., Opdam, F.L., Rasco, D., Vermaat, J.S., Crossman, T., Zajac, M., Hainline, A., Kremer, B., Barbash, O., Gounder, M.M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S746-S747 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|